Novo Nordisk Farma SRL

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company owns the widest portfolio of products for diabetes and also the most advanced insulin delivery devices. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.

Novo Nordisk is present in Romania since 1992.

As national leader in diabetes treatment, Novo Nordisk aims to develop Corporate Social Responsibility actions dedicated to persons with diabetes. Novo Nordisk aims to raise awareness regarding diabetes prevalence and to propose solutions that can diminish the human and financial effort.

„Changing Diabetes” is a CSR campaign implemented in Romania in 2008. ‘Changing diabetes’ is about leadership, about making a difference to the world of diabetes today and tomorrow. Changing Diabetes allows us to communicate all the things we do to lead the fight against diabetes.

“Changing possibilities in haemophilia” is about our aspiration for leadership in haemophilia care in terms of: addressing significant unmet patient needs, improving patient access to care, providing consistent reliable supply of highest-quality products.